This site is intended for health professionals only

Evolva selected to acquire certain Fluxome assets


Evolva Holding SA (SIX: EVE) has announced it has entered an agreement to acquire certain assets owned by Fluxome Sciences A/S, a Danish private company that is in reconstruction. The agreement is subject to creditor and court approval, which is anticipated to occur in the next two weeks. Further information will be provided if approval is obtained. The transaction is not expected to change Evolva’s 2012 financial projections.
About Evolva
Evolva’s mission is to discover and provide innovative, sustainable ingredients for health, nutrition and wellness. Evolva uses biosynthetic and evolutionary technologies to create and optimise small molecule compounds and their production routes. For more information see

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine